Summary: Our experience with the determination of thyroxine (T 4 ) in serum using a homogeneous enzyme immunoassay technique (EMIT, Syva Corp.) is reported. The intra-assay precision of the EMIT Manual Thyroxine Assay was investigated with 2 different calibrator concentrations and showed coefficients of variation varying from 5-2% for thyroxine concentrations of 40 and 120 Mg/1 thyroxine respectively. The inter-assay precision was investigated with different series of calibrators and serum specimens. Coefficients of variation for the calibrators varied from 35-5 % in the range of 20-200 Mg/1 thyroxine and for the serum specimens in the range of 8-232 g/l thyroxine from 50-4%. The recovery of various amounts of thyroxine added to thyroxine-free serum varied between 91-103%. The cross reactivity of structurally related compounds such as: monoiodothyronine, diiodothyronine, triiodothyronine, triiodothyroacetic acid and tetraiodothyroacetic acid was investigated.
Introduction
The competitive protein binding assay described by Murphy &Pattee has provided the basis of many methods subsequently developed for the measurement of thyroxine :(T 4 ) in serum (1). The principle of their procedure was based on the competition between radiolabeled T 4 and serum T 4 for binding sites on thyroxine binding globulin.
Their method allowed the direct quantitation of T 4 without interferences from organic or inorganic iodides. This test, however, requires an initial extraction of thyroxine from serum proteins. The variation in the recovery of thyroxine during this procedure greatly affects accuracy and precision of the results (2). The development of a radioimmunoassay (RIA) for T 4 has resulted in a strong increase in sensitivity and 0340-076X/79/0315-0320S2.00specificity for the thyroxine determinations in serum (3, 4, 5) . By using antibodies specific to thyroxine, the T 4 radioimmunoassay method eliminated many of the interference problems associated with the competitive protein binding assay, thus improving the reliability of the test. Like competitive protein binding assay methods, however, the T 4 radioimmunoassay used radioactive components which have the disadvantages inherent to all radioisotopic methods when used in the routine clinical laboratory: special isotopic safety considerations, licensure requirements, decay of radiolabeled reagents, need for radiocounting equipment and in the method itself, the obligatory separation of antibody bound from unbound isotope. In 1975, Ullman et al. reported the development of an enzyme-multiplied immunoassay technique (EMIT) 1 ) for thyroxine, which could simultaneously eliminate all the above outlined disadvantages without sacrifice of the speed, specificity and sensitivity previously characteristic only of the radioimmunological methods (6) . The EMIT enzyme immunoassay for thyroxine used stable enzyme labels instead of radioisotopic labels. When the enzyme is activated, the chemical reaction that occurs can be monitored spectrophotometrically and since the enzymatic activity is inversely related to the total concentration of T 4 in the sample, quantitation of the total T 4 in serum can easily be performed. Furthermore, unlike radioimmunoassay procedures, the enzyme immunoassay for thyroxine is homogeneous and no separation step is required.
The procedure is straight forward and lends itself well to automation (6, 7) . Recently automated procedures for the determination of T 4 by EMIT on the AGA Autochemist (LKB, Bromma, Sweden) and the ABA-100 (Abbott, South Pasedena, California) have been reported (8, 9, 10) . These automated EMIT thyroxine assays yielded results that agreed well with those obtained by a radioimmunoassay and are, according to the investigators, good alternatives to the commonly used RIA procedures. Until now, no study has been published on the evaluation of the EMIT Manual Thyroxine Assay. This EMIT thyroxine kit is particularly of interest for use in those clinical laboratories which have only a limited number of thyroxine determinations and/or do not have an expensive automatic analyzer. In this paper we present The reagents in the kit were accurately prepared and properly stored according to the manufacturer's instructions (11).
Materials and Methods

Enzyme immunoassay (EMIT) of thyroxine
Instruments and settings
A Model 300 T spectrophotometer (Gilford, Oberlin, Ohio 44074), with digital readout was used to measure absorbances at 340 nm. The spectrophotometer was connected to a Model 2400 Timer-Printer (Syva, Palo Alto, CA) for printing the absorbance reading at a precise time (9 seconds) after activation by the flow-cell sampling control.
The temperature of the flow cell was set at 25.0°C. The sample volume was adjusted to 0.70 ml. Diluter dispensers from Syva were used for the addition of the various reagents.
A Model TXg thermostatic waterbath (Tamspn, Zoetermeer, The Netherlands) was used for incubation of the samples at 37.00 ± 0.05 °C. Eppendorf micropipettes of 50 μΐ with disposable tips were used to deliver serum samples, thyroxine serum calibrators and the serum pretreatnient solution. The assay was carried out in glass test tubes of 12 X 75 mm. A Genie Vortex mixer (Scientific Industries, Mineola, Ν.Ϋ.) was used for mixing the content of each tube after the successive additions of the reagents. A timing device (Tamson, Zoetermeer, The Netherlands) was employed for the timing of the 15 second interval and the 15 minutes of incubation time.
Procedure
The determination of thyroxine with the EMIT Manual Thyroxine Assay Kit was performed according to the manufacturer's directions (11). Contrary to these directions, however, the contents of each tube were each time mixed separately after the successive additions of the various reagents, instead of vortexing a whole rack at once as recommended in the directions. This modification was used to prevent inadequate mixing of the components. 
Instrument and setting
The radioactivity of the 125 I thyroxine bound to the antiserum and from the 125 I thyroxine solution in the total count tubes was counted in an automatic gamma counting system (Baird Atomic TRI-Gamma, The Hague, The Netherlands). Time setting of the instrument was 1.20 minutes in which about 30,000 counts were obtained from the total count test tubes.
Procedure
The determination of thyroxine with the T4 RIA (PEG) kit was performed according to the manufacturer's instructions (12). In our procedure serum samples and standard were incubated with the antiserum for 2 h at room temperature (22 to 25 °C).
Sample preparation
Human sera were stored at -20 °C until used. Thyroxine-free serum was prepared by adding 15 g of Dowex 50 W or Amberlite IRA 400 cation exchanger to 40 ml of serum. After mixing, the mixture was* stored overnight at 4°C. This treatment was repeated once. The removal of thyroxine (more than'99% by this procedure) was checked by addition .of a trace amount of serum occurred; no differences were found in the electrophoretic pattern of the serum proteins and in the TBG content. A number of spiked serum samples with thyroxine concentrations of 40,80, 120 and 200 μ §/1 respectively were prepared by diluting an aqueous stock solution of 2000 Mg/1 Ζ,-thyroxine with thyroxinefree serum.
Results
Standard curves
In figure 1 a mean standard curve for the EMIT Manual Thyroxine method is presented. This curve is the average of 11 standard curves, which were run on several days during a 2 month time period. The calibrators used for the construction of these curves were from 6 kits with the same lot number. 
Precision
Infra-Assay Precision
The intra-assay variation of the EMIT Manual T 4 Assay was determined by 10 replicate analyses of calibrators containing 40 and 120 Mg/1 of thyroxine. The coefficient of variation (CV) was 4.8% at a T 4 level of 39.6 ± 1.9 Mg/1 (mean ± SD) and 2.4% at 120.4 ± 2.9 μ §/1.
Inter-Α ssay Precision
The interassay (day-to-day) variation for both the EMIT and RIA T 4 method was determined by calculating the coefficient of variation for each calibrator concentration from the mean standard curve of each method (figure 1 and 2). The mean value ± SD of the absorbance (EMIT) or percentage bound radioactivity (RIA) of each calibrator was translated into a thyroxine concentration and resulting coefficients of variation (CV%) were plottedversus the thyroxine calibrator concentrations in figure 3 . Furthermore, the inter-assay variation was assessed by the replicate analysis of 5 patient samples of various thyroxine concentrations on 10 days during a 1 month period. The coefficient of variation was 50.0% at a T 4 level of 8 ± 4 Mg/1 (mean ± SD), 6.7% at 69 ± 5, 6.3% at 85 ± 5,5.2% at 168 ± 9 and 4.1% at 232 ± 10/zg/l.
Sensitivity
The EMIT Manual Thyroxine Assay has been designed for optimum sensitivity in the assay range 20 to 200 μ §/1. Outside this range amounts of about 10 μg/l can be determined with a coefficient of variation of ± 50% and of 240 μg/l with a coefficient of variation of 5%. 
Accuracy
The results for the recovery of thyroxine by the EMIT and RIA method are shown in 
Specificity
The specificity of the EMIT and RIA method was tested by the determination of the cross-reactivity of compounds structurally related to thyroxine. Thyroxine-free sera containing 100 Mg/1 of each compound were prepared and subsequently measured by both methods. The apparent thyroxine content of each sample is summarized in table 2 together with the serum concentration range of each compound normally found in human serum. (table 4) is probably due to a lower sensitivity of the EMIT method in the determination of concentrations higher than 200 μ §/1. The difference in matrix of the RIA and EMIT calibrators (equine and human serum) showed no marked influence on the EMIT and RIA assayed values (table 3 and 4) .
Comparison
Patient samples
The results of a comparative evaluation of 100 patient's sera obtained with the EMIT and the RIA method are shown in figure 4 . For the comparative study serum samples were selected with thyroxine concentrations ranging from 0-200 μg/l. the analyses of specimens by Tab. 2. Cross-reactivity of compounds related to thyroxine in the EMIT and RIA thyroxine assay. EMIT and RIA were performed in duplicate and the reiults were averaged, As none of these methods could bt indicated as more aoeurate, we calculated a regression line from an orthogonal instead of a linear regression analysis. This regression analysis of the paired data from 100 §era gave a correlation coefficient of 0.96, a slope of 0,91, and a y4ntercept of 3.37 μ&ΙΙ The mean value fgr thyfOXine in ttie patient's sera was 88.1 Mg/1 fQf the EMIT method and 88,5 μg/l for the RIA method:
Diagnosis of thyroid status
The comparisons between the EMIT method and RIA method in the diagnostic classification of 100 patients, based on the normal ranges of 4S-120 μι/l for EMIT (1 1) and SQ-130 Mg/1 for the RIA assay (12), showed a diagnostic agreement in 89 out ef the 100 patients, In Over a 2 month time period the variation in the mean standard curves, shown in figure 1 and 2, for both the EMIT and the RIA method was acceptable.
However, by plotting these standard deviations as coefficients of variation in the concentration versus the calibrator concentrations ( fig. 3) , it can be seen that especially the use of a mean EMIT standard curve for the calculation of the concentration of the samples is not acceptable. Therefore using the EMIT method for the thyroxine determination, it is essential to run a calibration curve each day of analysis. The intra-assay precision of the EMIT Method is satisfactory with a coefficient of variation ranging from 2.4-4.8%. Except for the specimen with a T 4 level of 8 Mg/1, which had a coefficient of variation of 50%, the interassay variations in values obtained by EMIT for the same specimens were quite acceptable (coefficient of variation 4.1-6.7%) during the 4 weeks in which this variable was measured. The analytical recovery for both methods was good and varied for EMIT from 91-103% and for the RIA method from 97-107%. Cross reactions for triiodothyronine and tetraiodothyroacetic acid were observed for the EMIT as well as the RIA assay. However from the levels normally found for the 2 compounds in human serum it can be concluded that they will have no clinically significant influence on the serum thyroxine concentration measured with both methods. From the good correlation (r = 0.955) between serum thyroxine concentrations obtained by the EMIT and RIA method it can be concluded that these assay techniques are equivalent. In addition, there was satisfactory agreement between the two methods in the diagnosis of the thyroid status. Thus, the EMIT Manual Thyroxine Assay is a good alternative for RIA methods and is especially suitable in hospital laboratories which may not have faculties for radioimmunoassay. Furthermore, compared to the T 4 RIA (PEG) procedure, the EMIT Manual Thyroxine Assay has the advantage that the technique is simpler and faster and can be adapted more easily to automation. The total time of analysis of 40 unknown specimens in duplicate together with 5 calibrators in duplicate took about 4 h in the EMIT procedure and about 6 h in the RIA assay. For the reasons described in the introductory paragraphs and in the present study, we recommend the EMIT assay for analysis of serum thyroxine in the range of 20-200 Mg/1.
